TOP TIERMARKET NEWSWIRE
News & sentiment

ZENAS BIOPHARMA INC Equity (ZBIO) — News & AI sentiment

ZENAS BIOPHARMA INC Equity (ZBIO) news roundup. 4 stories in the past week, 11 over 30 days. Average 30-day sentiment is 53.3/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
4
avg sentiment 49/100
30d stories
11
avg sentiment 53.3/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

ZBIO news in the last 24 hours, 7 days, 30 days and 90 days

How much ZBIO coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowZBIO storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days449/100ZBIO headlines →
Last 30 days1153.3/100ZBIO headlines →
Last 90 days2254.8/100ZBIO headlines →

Latest stories on ZBIO

2d ago
3d ago
5d ago
Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event
Business Insider56 · neutralproduct/pr
5d ago
Sep 4
Sep 4
Aug 18
Aug 18
Aug 17
Aug 17
Aug 16
Aug 13
Aug 13
Zenas BioPharma, Inc. (ZBIO) files 8-K
SEC 8-K50 · neutralgeneral
Aug 13
Aug 13
Aug 13
Jul 17
Jul 17
Jul 14
Jul 10
Jun 21
Jun 17
Jun 11
Jun 2
May 28
Open ZBIO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →